The Future of Remote Work at BenchSci
Working on a fully remote basis for several months has been an enlightening experience that inspired us to revise our work-from-home policy for the future.
Expanded Antibody Validation and More New Features on BenchSci
We’re excited to announce several new features to our platform, including expanded antibody validation and enhancements to our verification filter.
Lessons Learned from Interviewing 500+ Software Engineers
Our VP of Engineering, Asaf Inger, has interviewed over 500 job applicants and often sees them struggle with a few key elements, which he discusses here.
Cell Products Now on BenchSci!
To help scientists run more successful experiments, we added over 514,000 cell products to our AI-Assisted Reagent Selection platform.
We Remotely Onboarded 29 New Employees During COVID-19. Here’s How.
Creating an engaging onboarding experience for new team members has added challenges in our new, fully-remote setting. Here’s how we’ve adapted.
Find Antibodies Verified According to the 5 Nature Pillars of Validation, Plus 2 Additional Pillars
BenchSci’s Verification filter has been enhanced to include antibodies verified according to Nature’s 5 pillars of verification, plus 2 additional pillars
What Embracing Transparency Looks Like at BenchSci
At BenchSci, transparency is one of our core values. Our CEO, Liran Belenzon, explains why we decided to found our culture on trust, not fear.
Digital R&D Solutions for a Safe and Productive Return to the Lab
As COVID lockdowns end, scientists returning to the lab face new challenges. Digital R&D technology such as software and lab automation offer solutions.
The Disregard of Preclinical R&D Software Is Hurting Science—but There’s Hope (Part 3 of 3)
Read how the lack of software innovation for preclinical R&D exacerbates pharma’s productivity crisis, and what we can do to address it.